Aethlon Medical's three largest insider shareholders as of September 29, 2026 are Sabrina Martucci Johnson (Director, 4 shares), Edward G Broenniman (Director, 0 shares), Chetan Shah (Director, 0 shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Sabrina Martucci Johnson | Director | 4 | 0 | 4 | 99.1% | 31 Mar, 2022 |
| 2 | Edward G Broenniman | Director | 0 | 0 | 0 | 0.2% | 01 Jul, 2026 |
| 3 | Chetan Shah | Director | 0 | 0 | 0 | 0.2% | 01 Jul, 2026 |
| 4 | Angela Rossetti | Director | 0 | 0 | 0 | 0.2% | 21 Apr, 2026 |
| 5 | Nicolas Gikakis | Director | 0 | 0 | 0 | 0.2% | 01 Jul, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 30 Jun, 2026 | Edward G Broenniman | Director | Disposed F | 1,091 | $2,459,877.01 | $2.68Bn | 0 | Direct |
| 30 Jun, 2026 | Nicolas Gikakis | Director | Disposed F | 2,182 | $2,459,877.01 | $5.37Bn | 0 | Direct |
| 30 Jun, 2026 | Chetan Shah | Director | Disposed F | 2,182 | $2,459,877.01 | $5.37Bn | 0 | Direct |
| 17 Apr, 2026 | Nicolas Gikakis | Director | Acquired A | 21,815 | $6,869,656.52 | $149.86Bn | 0 | Direct |
| 17 Apr, 2026 | Edward G Broenniman | Director | Acquired A | 21,815 | $6,869,656.52 | $149.86Bn | 0 | Direct |
| 17 Apr, 2026 | Angela Rossetti | Director | Acquired A | 21,815 | $6,869,656.52 | $149.86Bn | 0 | Direct |
| 17 Apr, 2026 | Chetan Shah | Director | Acquired A | 21,815 | $6,869,656.52 | $149.86Bn | 0 | Direct |
| 31 Mar, 2026 | Edward G Broenniman | Director | Disposed F | 89 | $6,569,671.52 | $584.70Mn | 0 | Direct |
| 31 Mar, 2026 | Chetan Shah | Director | Disposed F | 178 | $6,569,671.52 | $1.17Bn | 0 | Direct |
| 31 Mar, 2026 | Nicolas Gikakis | Director | Disposed F | 178 | $6,569,671.52 | $1.17Bn | 0 | Direct |
| 31 Dec, 2025 | Chetan Shah | Director | Disposed F | 179 | $8,309,584.52 | $1.49Bn | 0 | Direct |
| 31 Dec, 2025 | Nicolas Gikakis | Director | Disposed F | 179 | $8,309,584.52 | $1.49Bn | 0 | Direct |
| 31 Dec, 2025 | Edward G Broenniman | Director | Disposed F | 89 | $8,309,584.52 | $739.55Mn | 0 | Direct |
| 30 Sep, 2025 | Nicolas Gikakis | Director | Disposed F | 1,786 | $449,377.53 | $802.59Mn | 0 | Direct |
| 30 Sep, 2025 | Chetan Shah | Director | Disposed F | 1,786 | $449,377.53 | $802.59Mn | 0 | Direct |
| 30 Sep, 2025 | Edward G Broenniman | Director | Disposed F | 893 | $449,377.53 | $401.29Mn | 0 | Direct |
| 30 Jun, 2025 | Chetan Shah | Director | Disposed F | 1,786 | $719,964.00 | $1.29Bn | 0 | Direct |
| 30 Jun, 2025 | Edward G Broenniman | Director | Disposed F | 893 | $719,964.00 | $642.93Mn | 0 | Direct |
| 30 Jun, 2025 | Nicolas Gikakis | Director | Disposed F | 1,786 | $719,964.00 | $1.29Bn | 0 | Direct |
| 23 Apr, 2025 | Angela Rossetti | Director | Acquired A | 142,857 | $20,998.95 | $3.00Bn | 6 | Direct |